Pharmaceutical PV DIV - FSB

Active Indefinite Delivery Contract Awarded Last action

Contract number
SPE2DR25D9363
Awardee
Awarding agency
Task orders
16 $244,261 obligated

Award facts

Opportunity
Combined order value
$244,261 Current and potential, with all options
Last date to order 9% complete
IDV ceiling 5% used
$4,999,999.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The federal contract IDV award is for an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at up to $4,999,999, is to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.

The IDC covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract enables the DLA to issue firm fixed-price delivery orders for these pharmaceutical items to support the medical supply needs of Department of Defense (DoD) healthcare sites globally. The IDC has an ultimate completion date of December 31, 2036 and was awarded on November 13, 2025. This contract is not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Task orders

Task order Ordering agency Obligated Awarded
Surgilube lubricant 3GM SPE2DR26FGHM7 Defense Logistics Agency $49
Ilaris 150 MG/ML vialml SPE2DR26FGHM6 Defense Logistics Agency $43,929
Surgilube lubricant 3GM SPE2DR26FGHM5 Defense Logistics Agency $49
Ilaris 150 MG/ML vialml SPE2DR26FGHM4 Defense Logistics Agency $43,929
Mirena 52 MG systems SPE2DR26FGHM3 Defense Logistics Agency $5,475
Surgilube lubricant 3GM SPE2DR26FGHM2 Defense Logistics Agency $49
Ilaris 150 MG/ML vialml SPE2DR26FGHM1 Defense Logistics Agency $29,286
YF-VAX 1 dose vials SPE2DR26FGHM0 Defense Logistics Agency $1,889
Iosat 130 MG tablet 14S SPE2DR26FGHL9 Defense Logistics Agency $2,419
Surgilube lubricant 3GM SPE2DR26FGHL8 Defense Logistics Agency $24
Tamiflu 6 MG/ML suspension 60ML SPE2DR26FGHL7 Defense Logistics Agency $465
Ilaris 150 MG/ML vialml SPE2DR26FGHL6 Defense Logistics Agency $29,286
Ilaris 150 MG/ML vialml SPE2DR26FGHL5 Defense Logistics Agency $29,286
Ilaris 150 MG/ML vialml SPE2DR26FGHL4 Defense Logistics Agency $29,286
Mirena 52 MG systems SPE2DR26FGHL2 Defense Logistics Agency $2,657
Ilaris 150 MG/ML vialml SPE2DR26FGHL1 Defense Logistics Agency $26,183
Show all 16

Quick answers

Who was awarded contract SPE2DR25D9363?

SPE2DR25D9363 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.

How much is contract SPE2DR25D9363 worth?

Orders under SPE2DR25D9363 have obligated $244,261. SPE2DR25D9363's own ceiling is $4,999,999.

How many orders have been placed under contract SPE2DR25D9363?

16 orders have been placed under SPE2DR25D9363, the latest on June 8, 2026.

Who can order from contract SPE2DR25D9363?

SPE2DR25D9363 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract SPE2DR25D9363 competed?

The extent of competition for SPE2DR25D9363 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV